CVS vs LMAT · P/E 16, rev $402.07B vs P/E 35, rev $219.9M
CVS Health Corp (CVS) versus LeMaitre Vascular Inc (LMAT) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported LMAT revenue for 2024-12-31 was $219.9M. Net income was $44.0M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Not investment advice. Open the CVS and LMAT stock pages for the full models.
Not investment advice.